Veracyte
VCYT
#3651
Rank
S$4.56 B
Marketcap
S$57.81
Share price
-6.01%
Change (1 day)
0.81%
Change (1 year)

Revenue for Veracyte (VCYT)

Revenue in 2025 (TTM): S$0.65 Billion

According to Veracyte's latest financial reports the company's current revenue (TTM ) is S$0.64 Billion. In 2024 the company made a revenue of S$0.60 Billion an increase over the revenue in the year 2023 that were of S$0.47 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Veracyte from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) S$0.65 B7.37%
2024 S$0.60 B27.07%
2023 S$0.47 B19.95%
2022 S$0.39 B33.96%
2021 S$0.29 B90.94%
2020 S$0.15 B-4.22%
2019 S$0.16 B29.1%
2018 S$0.12 B30.61%
2017 S$96.23 M2.17%
2016 S$94.19 M34.52%
2015 S$70.02 M38.76%
2014 S$50.46 M82%
2013 S$27.72 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Exact Sciences
EXAS
S$3.99 B 522.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-S$4.46 Million-100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
S$1.06 B 66.68%๐Ÿ‡บ๐Ÿ‡ธ USA